Today peptides, tomorrow homeopathy (...though at least for the latter, a presumption of safety would have a more rational basis) Eric, what feels especially important here is that the difficult question is not only whether a biological signal exists, but whether the strength of evidence matches the level of confidence required for clinical use
Dr Dan Reardon, a UK A&E physician who sees peptide-related cases in emergency departments, frames it as a basic-rigour problem
The practical solution Many researchers address this by reconstituting only what they need for roughly four weeks of dosing
A 2007 study conducted in Russia found that epithalon extended the lifespan of rats exposed to natural and constant illumination [9]
The biological evidence is robust at the cellular level, and clinical results are promising but limited by small study sizes, industry sponsorship, and absence of independent replication
Results:May vary from person to person